Agenda (in Eastern Time):

8:00 — Welcome and Roll Call

8:15 — Influenza Vaccines

• Introduction
• Flublok in older children and adolescents: immunogenicity and safety
• Estimates of influenza burden and burden averted through vaccination
• Proposed recommendations for 2025-26
• Presentation regarding thimerosal in vaccines
• Proposed recommendations regarding thimerosal containing influenza vaccine

10:15 — Break

10:30 — Chikungunya Vaccines

• Introduction
• EtR (partial) for use of live attenuated and virus-like particle chikungunya vaccines in U.S territories
• Safety update on live attenuated chikungunya vaccine and use among older persons

10:45 — Anthrax Vaccine

10:50 — MMRV Vaccine

• Presentation on MMRV vaccine in children under under 5 years of age
• Proposed recommendations regarding MMRV in children under 5 years of age

11:20 — Break

11:30 — Public Comment

12:15 — Break

12:30 — Votes

• Influenza Vaccines
• Thimerosal containing influenza vaccine recommendations

1:00 — Adjourn